Predictions
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.36
05.03.23
05.03.23
-
05.03.24
05.03.24
-35.75%
06.03.24
06.03.24
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
01.03.23
01.03.23
€14.00
-
02.03.23
02.03.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.36
26.02.23
26.02.23
-
26.02.24
26.02.24
-35.75%
27.02.24
27.02.24
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.42
22.01.23
22.01.23
-
22.01.24
22.01.24
12.21%
05.02.23
05.02.23
Could be very worthwhile Investment >20% year
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
21.01.23
21.01.23
-
24.05.24
24.05.24
-
26.01.23
26.01.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Growpros Cannabis Ventures Inc
Start price
Target price
Perf. (%)
€0.012
15.01.23
15.01.23
€0.15
15.01.24
15.01.24
4.17%
16.01.24
16.01.24
Sernova Corp.
Start price
Target price
Perf. (%)
€0.65
05.01.23
05.01.23
€25.00
05.02.23
05.02.23
23.66%
06.02.23
06.02.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.46
04.01.23
04.01.23
€12.00
31.12.25
31.12.25
63.49%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.55
03.01.23
03.01.23
-
03.01.24
03.01.24
78.44%
14.05.23
14.05.23
Could be worthwhile Investment >10% per year
Sernova Corp.
Start price
Target price
Perf. (%)
€0.53
30.12.22
30.12.22
€5.00
30.12.25
30.12.25
-10.84%
15.12.23
15.12.23
Could be very worthwhile Investment >20% year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.80
10.12.22
10.12.22
-
10.12.23
10.12.23
-21.61%
24.12.22
24.12.22
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.58
21.11.22
21.11.22
-
21.11.23
21.11.23
-85.09%
22.11.23
22.11.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.80
19.11.22
19.11.22
€2.00
19.11.23
19.11.23
-41.00%
20.11.23
20.11.23
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.63
19.11.22
19.11.22
€2.50
19.11.23
19.11.23
-46.91%
11.03.23
11.03.23
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.58
17.11.22
17.11.22
-
17.11.23
17.11.23
-14.78%
26.12.22
26.12.22
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.88
16.11.22
16.11.22
-
16.11.23
16.11.23
-90.21%
17.11.23
17.11.23